PROK
PROKIDNEY CORP.
NASDAQ · Healthcare · Biotechnology · US
$1.91
+6.11%Margins
Gross margin
-252.6%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
9.8%
Return on equity
-34.8%
Return on assets
20.1%
Return on invested capital
0.00x
Asset turnover
-$141.2M
Cash from operations
$0.87
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026